Published in Arch Intern Med on February 12, 2007
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Using benefit-based tailored treatment to improve the use of antihypertensive medications. Circulation (2013) 1.89
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2014) 1.65
The role of aspirin in women's health. Int J Womens Health (2011) 1.39
Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines. BMC Med (2013) 1.27
Individual and population benefits of daily aspirin therapy: a proposal for personalizing national guidelines. Circ Cardiovasc Qual Outcomes (2011) 1.11
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
Cost-utility of aspirin and proton pump inhibitors for primary prevention. Arch Intern Med (2011) 1.05
The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population. BMJ Open (2011) 0.90
Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis. Value Health (2011) 0.88
Aspirin for primary prevention of cardiovascular disease in diabetes mellitus. Nat Rev Endocrinol (2010) 0.86
Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men. J Gen Intern Med (2013) 0.85
Cost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetes. Diabetes Care (2010) 0.80
Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease. J Am Heart Assoc (2015) 0.79
Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention. Ann Fam Med (2017) 0.78
The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients. Appl Health Econ Health Policy (2017) 0.77
Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis. Circulation (2011) 0.77
Aspirin was cost-effective for primary prevention of cardiovascular events in older women at moderate risk. ACP J Club (2007) 0.76
Cost-effectiveness of oral antiplatelet agents--current and future perspectives. Nat Rev Cardiol (2011) 0.76
Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey. BMJ Open (2015) 0.75
Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04
Adolescent overweight and future adult coronary heart disease. N Engl J Med (2007) 5.74
Racial differences in incident heart failure among young adults. N Engl J Med (2009) 5.60
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med (2004) 3.64
Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med (2010) 2.78
Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med (2006) 2.73
Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med (2015) 2.72
Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation (2011) 2.64
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Self-reported racial discrimination and substance use in the Coronary Artery Risk Development in Adults Study. Am J Epidemiol (2007) 2.40
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging (Albany NY) (2008) 2.35
Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical data. J Manag Care Pharm (2007) 2.24
Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst (2005) 2.21
Overly aggressive new guidelines for lipid screening in children: evidence of a broken process. Pediatrics (2012) 1.95
Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin. J Gen Intern Med (2009) 1.77
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2014) 1.65
Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ (2006) 1.65
Nighttime blood pressure dipping in young adults and coronary artery calcium 10-15 years later: the coronary artery risk development in young adults study. Hypertension (2012) 1.56
Alcohol consumption in young adults and incident hypertension: 20-year follow-up from the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol (2010) 1.54
Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis. Am Heart J (2012) 1.46
Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk. Circ Cardiovasc Qual Outcomes (2015) 1.40
Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol (2004) 1.37
Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol (2011) 1.31
Early adult to midlife cardiovascular risk factors and cognitive function. Circulation (2014) 1.28
Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine. Exp Clin Psychopharmacol (2008) 1.20
Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment. J Gen Intern Med (2008) 1.20
Do smokers of menthol cigarettes find it harder to quit smoking? Nicotine Tob Res (2010) 1.15
Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis (2013) 1.13
Illicit drug use in young adults and subsequent decline in general health: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Drug Alcohol Depend (2006) 1.11
An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine (Baltimore) (2005) 1.08
Trajectories of drug use and mortality outcomes among adults followed over 18 years. J Gen Intern Med (2012) 1.04
Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA (2004) 1.04
Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLoS One (2012) 1.03
Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 1.02
Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update (2010) 1.01
History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the Coronary Artery Risk Development in Young Adults study. J Am Heart Assoc (2014) 0.99
The association of cigarette smoking with self-reported disease before middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Prev Med (2006) 0.97
Physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010. J Gen Intern Med (2013) 0.96
Telomerase, telomere length, and coronary artery calcium in black and white men in the CARDIA study. Atherosclerosis (2011) 0.94
Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Endocr Relat Cancer (2013) 0.92
Fatherhood and the risk of cardiovascular mortality in the NIH-AARP Diet and Health Study. Hum Reprod (2011) 0.90
Budget impact analysis: review of the state of the art. Expert Rev Pharmacoecon Outcomes Res (2005) 0.90
Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial. J Hypertens (2012) 0.90
Compliance by California tanning facilities with the nation's first statewide ban on use before the age of 18 years. J Am Acad Dermatol (2013) 0.89
Missed opportunities for treatment of uncontrolled hypertension at physician office visits in the United States, 2005 through 2009. Arch Intern Med (2012) 0.88
Candidate molecular pathway genes related to appetite regulatory neural network, adipocyte homeostasis and obesity: results from the CARDIA Study. Ann Hum Genet (2010) 0.88
Short wait times for patients seeking cosmetic botulinum toxin appointments with dermatologists. J Am Acad Dermatol (2007) 0.87
Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt) (2013) 0.86
Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men. J Gen Intern Med (2013) 0.85
Epidemiologic studies of isoflavones & mammographic density. Nutrients (2010) 0.84
Frequent use of emergency medical services by the elderly: a case-control study using paramedic records. Prehosp Disaster Med (2010) 0.84
Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol (2005) 0.84
Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model. J Gen Intern Med (2015) 0.82
Alternatives to estrogen for treatment of hot flashes: are they effective and safe? JAMA (2006) 0.81
Use of coronary calcification scores to predict coronary heart disease. JAMA (2004) 0.81
Tracking varicella deaths: accuracy and completeness of death certificates and hospital discharge records, New York State, 1989-1995. Am J Public Health (2002) 0.81
Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas (2004) 0.80
Re: Childhood lipid screening: evidence and conflicts. Pediatrics (2013) 0.79
Lactation Duration and Midlife Atherosclerosis. Obstet Gynecol (2015) 0.78
Blood pressure matters, even during young adulthood. J Am Coll Cardiol (2011) 0.78
"On the other hand ...": the evidence does not support the use of hand-carried ultrasound by hospitalists. J Hosp Med (2010) 0.78
Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice. Am J Med (2013) 0.78
Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol. Pharmacotherapy (2013) 0.78
Modeling cardiovascular disease prevention. JAMA (2010) 0.77
Public health impact of statin prescribing strategies based on JUPITER. Prev Med (2010) 0.77
Disparities in opioid prescribing for patients with psychiatric diagnoses presenting with pain to the emergency department. Emerg Med J (2011) 0.77
Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis. Circulation (2011) 0.77
Change in physical activity after smoking cessation: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Addiction (2014) 0.76
What about other causes of death? Arch Intern Med (2006) 0.75
Coronary calcium screening. N Engl J Med (2009) 0.75
Does age modify effectiveness of statin therapy in coronary artery disease? Ann Intern Med (2010) 0.75
Vitamin D as a mediator of racial differences in blood pressure. J Gen Intern Med (2011) 0.75
Nomogram for exercise capacity in women. N Engl J Med (2005) 0.75
Evidence at the point of practice change: lung cancer screening. Arch Intern Med (2012) 0.75
Coronary calcium scoring and cardiovascular risk: the SHAPE of things to come. Arch Intern Med (2008) 0.75
Associations of retrospective and concurrent lipid levels with subclinical atherosclerosis prediction after 20 years of follow-up: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Ann Epidemiol (2013) 0.75
Validation of triage criteria for deciding which apparently inebriated persons require emergency department care. Emerg Med J (2010) 0.75
Do medications affect vital signs in the prehospital treatment of acute decompensated heart failure? Prehosp Emerg Care (2006) 0.75
Point-counterpoint: soy intake for breast cancer patients. Integr Cancer Ther (2002) 0.75